Cargando…

Impaired Butyrate Induced Regulation of T Cell Surface Expression of CTLA-4 in Patients with Ulcerative Colitis

Patients with ulcerative colitis (UC) have reduced intestinal levels of short-chain fatty acids (SCFAs), including butyrate, which are important regulators of host–microbiota crosstalk. The aim was therefore to determine effects of butyrate on blood and intestinal T cells from patients with active U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magnusson, Maria K., Vidal, Alexander, Maasfeh, Lujain, Isaksson, Stefan, Malhotra, Rajneesh, Olsson, Henric K., Öhman, Lena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002718/ https://www.ncbi.nlm.nih.gov/pubmed/33802979 http://dx.doi.org/10.3390/ijms22063084

Ejemplares similares

Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During Remission
por: Maasfeh, Lujain, et al.
Publicado: (2021)

The Anti-inflammatory Immune Regulation Induced by Butyrate Is Impaired in Inflamed Intestinal Mucosa from Patients with Ulcerative Colitis
por: Magnusson, Maria K., et al.
Publicado: (2019)

Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
por: Öhman, Lena, et al.
Publicado: (2021)

Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice
por: Jourova, Lenka, et al.
Publicado: (2022)

Spontaneous Colitis in Muc2-Deficient Mice Reflects Clinical and Cellular Features of Active Ulcerative Colitis
por: Wenzel, Ulf A., et al.
Publicado: (2014)

Butyrate Protects Myenteric Neurons Loss in Mice Following Experimental Ulcerative Colitis
por: Caetano, Marcos A. F., et al.
Publicado: (2023)

Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018)

Vitamin D Increases CTLA-4 Gene Expression in Patients with Mild to Moderate Ulcerative Colitis
por: Sharifi, Amrollah, et al.
Publicado: (2019)

Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome
por: Satka, Stefan, et al.
Publicado: (2022)

Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients
por: Zhou, Zheng, et al.
Publicado: (2021)

Taxifolin Alleviates DSS-Induced Ulcerative Colitis by Acting on Gut Microbiome to Produce Butyric Acid
por: Li, Wei, et al.
Publicado: (2022)

Health-related quality of life in patients with long-standing ulcerative colitis in remission
por: Mavroudis, Georgios, et al.
Publicado: (2022)

Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms
por: Moraes, Luiza, et al.
Publicado: (2020)

Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation
por: Xu, Hao-Ming, et al.
Publicado: (2021)

Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients
por: Osawa, Motoyasu, et al.
Publicado: (2023)

Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement
por: Dong, Weimin, et al.
Publicado: (2022)

Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis
por: Ikeda, Yuka, et al.
Publicado: (2023)

Macrophage and dendritic cell subsets in IBD: ALDH(+) cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation
por: Magnusson, Maria K, et al.
Publicado: (2015)

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study
por: Vernero, Marta, et al.
Publicado: (2020)

Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial
por: Nyman, Margareta, et al.
Publicado: (2020)

Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease
por: Mavroudis, Georgios, et al.
Publicado: (2019)

Management of ulcerative colitis
por: Fell, John M, et al.
Publicado: (2016)

PSYCHIATRIC FACTORS IN ULCERATIVE COLITIS
por: Chakraborty, P.K., et al.
Publicado: (1983)

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022)

ULCERATIVE COLITIS
Publicado: (1969)

Ulcerative Colitis: Shifting Sands
por: D’Haens, Geert R. A. M., et al.
Publicado: (2019)

Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis
por: Dou, Xiujing, et al.
Publicado: (2020)

Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway
por: Tang, Xiaonan, et al.
Publicado: (2020)

Prevention of Ulcerative Colitis in Mice by Sweet Tea (Lithocarpus litseifolius) via the Regulation of Gut Microbiota and Butyric-Acid-Mediated Anti-Inflammatory Signaling
por: He, Xiao-Qin, et al.
Publicado: (2022)

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
por: Loftus, Edward V, et al.
Publicado: (2022)

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids
por: Iribarren, Cristina, et al.
Publicado: (2022)

Laparoscopic pouch surgery in ulcerative colitis
por: Hemandas, Anil K., et al.
Publicado: (2012)

Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis
por: Vancamelbeke, Maaike, et al.
Publicado: (2019)

Efficacy of a Preparation Based on Calcium Butyrate, Bifidobacterium bifidum, Bifidobacterium lactis, and Fructooligosaccharides in the Prevention of Relapse in Ulcerative Colitis: A Prospective Observational Study
por: Caviglia, Gian Paolo, et al.
Publicado: (2021)

Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats
por: Zhang, Mingming, et al.
Publicado: (2016)

Effect of Size and Loading of Retinoic Acid in Polyvinyl Butyrate Nanoparticles on Amelioration of Colitis
por: Li, Jinting, et al.
Publicado: (2021)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Ulcerative Colitis in Infancy
por: Rukunuzzaman, Md, et al.
Publicado: (2011)

Chronic Ulcerative Colitis
por: Sen, S. C.
Publicado: (1939)

Chronic Ulcerative Colitis
por: Chopra, R. N., et al.
Publicado: (1939)

Cannot write session to /tmp/vufind_sessions/sess_7mvjsleaufqoid6fl9es8su1bf